pLenti-mCherry-CDK4KTR Citations (1)

Originally described in: Stress-mediated exit to quiescence restricted by increasing persistence in CDK4/6 activation.
Yang HW, Cappell SD, Jaimovich A, Liu C, Chung M, Daigh LH, Pack LR, Fan Y, Regot S, Covert M, Meyer T Elife. 2020 Apr 7;9. pii: 44571. doi: 10.7554/eLife.44571. PubMed Journal

---

Articles Citing pLenti-mCherry-CDK4KTR

Articles
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer. Nehme J, Maassen S, Bravaccini S, Zanoni M, Gianni C, De Giorgi U, Soto-Gamez A, Altulea A, Gheorghe T, Wang B, Demaria M. EMBO J. 2025 Apr;44(7):1921-1942. doi: 10.1038/s44318-025-00371-x. Epub 2025 Feb 10. PubMed

If you have published an article using this material, please email us at to have your article added to this page.